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Introduction: The age of menopause is a time of many changes in the psychophysical-social functioning 
of women, with reduced ovarian hormonal activity and estrogen levels. The most common, troublesome symp-
toms of menopause age include depressive disorders, sleep disorders, sexual dysfunction, discomfort associ-
ated with muscle pain, joint aches, osteoporosis and characteristic hot flashes.
Aim of the study is to determine and compare the rate of menopausal symptoms among women living in 
continents of both Americas, Africa, Australia and Eurasia.
Material and methods: The results of this work were obtained in 2014 on the basis of the data from a re-
view of the 64 most important studies using the PubMed database. Research published in the period 2000-
2014, from Africa, both Americas, Australia and Eurasia, were taken into account. 
Results: The prevalence of menopausal symptoms in African women is disconcertingly high. Women from 
South America complain about occurrence of depressive, sexual dysfunctions and discomfort associated with 
muscle pain and joint aches. Symptoms most reported by women in the United States are pains associated with 
muscles and joints. Women in Australia suffer mainly due to vasomotor symptoms and sexual dysfunction, while 
in the group of women surveyed in Asia there is observed an alarming increase in the proportion of women report-
ing depressive disorders. In Europe there was a much greater incidence of sleep disorders and depressive disorders.
Conclusions: Women around the world suffer from ailments characteristic for the menopausal period re-
gardless of ethnic origin, skin color or socio-demographic factors. 
Key words: menopause, menopausal symptoms, depression, sexuality.
Introduction
The intensity and type of sensations perceived as 
menopausal symptoms vary from individual to individ-
ual. They depend mainly on the levels of sex hormones 
(including hormone replacement therapy) and the psy-
chophysical-social state of women [1].
The early menopausal symptoms related to the pro-
gressive reductions in hormonal secretion and ovarian 
estrogen deficiency in the literature include hot flashes, 
sweating, sleep disorders, mental changes and men-
strual disorders. Later in the menopause period there 
also appear urogenital atrophic changes and related 
sexual dysfunctions, cardiovascular diseases, osteopo-
rosis, and musculoarticular complaints [2].  
About 85% of menopausal women report at least 
one of the symptoms of menopause, usually suggest-
ing the presence of depressive disorders, vasomotor 
symptoms or sleep disorders [3, 4]. 
The presence of typical symptoms of menopause 
can be a cause of depressive disorders.
During menopause a characteristic sleep disorder 
is insomnia, which is the most common symptom of 
depressive disorders and includes sleep impairment 
such as:
•	 disorders of sleep continuity – the shortening of slow-
wave sleep, REM sleep abnormalities,
•	 early waking – characteristic of depressive disorders,
•	 sleep disorders – characteristic of anxiety disorders [5].
Insomnia is the problem of sleep which does not 
provide adequate rest or difficulty in falling asleep (la-
tency) and maintaining sleep (interrupted sleep) [6] and 
is most common in the general population, which has 
a close relationship with the development of civilization 
and detachment from the natural rhythms of life. 
Many authors agree with the occurrence of distur-
bances during menopause [7, 8]. In many cases, the 
occurrence of depression among women in the climac-
teric period is preceded by earlier episodes of mood 
disorders [9]. It can also be assumed that estrogen 
deficiency in the climacteric period causes different 
ailments having a close link with symptoms of depres-
sive disorders [10, 11]. Estrogens increase the activity 
of serotonin in the brain – a neurotransmitter that af-
fects the mood of a woman. The relationship between 
the level of follicle-stimulating hormone (FSH), estradiol 
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(E2) and testosterone (T) was examined and their role 
in the emergence of depressive in the climacteric period 
was recorded [12]. 
The World Health Organization (WHO) suggests 
that currently depressive disorders are the fourth most 
serious health problem in the world, in 2020 will be-
come the second problem after ischemic heart disease, 
and even will dominate in the second position by 2030 
[13]. Depressive disorders may be present in up to 
70% of cases of chronic diseases. Very often they are 
diagnosed in the course of the metabolic syndrome or 
osteoporosis, characteristic for menopausal age [14]. 
The characteristic symptoms of sexual dysfunction 
in menopausal disorders are libido disorders, genital 
inflammation, and painful sexual intercourse. The re-
sults indicate that the majority of women remain sexu-
ally active during this time, but a large group of women 
report a  decrease in sexual activity, decreased libido, 
and avoidance of intercourse – approximately 60% of 
patients [15]. 
Sexual activity in menopausal women is associated 
with a  partner [16], physical and mental health [17], 
and the use of estrogen therapy. 
The Classification of the American Psychiatric Asso-
ciation DSM-IV includes common sexual dysfunctions 
in perimenopause:
•	 disorders or lack of sexual desire,
•	 sexual arousal disorder,
•	 orgasmic disorders,
•	 sexual disorders associated with pain (dyspareunia) [18].
Aspects of female sexuality are shaped through the 
centuries by the cultural community life of the woman. 
Cultural considerations are of great importance in deal-
ing with women’s sexual symptoms arising from physi-
ological changes. Women are not willing to share their 
intimate problems even in a doctor’s office, but more 
often as a result of the dissemination of mass culture 
women are encouraged to solve their sexual problems, 
especially during menopause [19]. Scientists claim that 
sexual activity in the mature years of life is the key to 
satisfying aging [20]. 
Aim of the study
The aim of the study is to examine and compare 
prevalence of menopausal symptoms in women living 
in Africa, both Americas, Australia and Eurasia.
Material and methods
The results of this study were developed in 2014 
based on data from the most relevant available 64 
studies using the PubMed database. Studies published 
in the years 2000-2014, originating from Africa, both 
Americas, Australia and Eurasia, were included. 
Data on Africa were obtained on the basis of five 
studies conducted in Nigeria, Egypt and Libya, pub-
lished in the period 2009-2012 [21-25]. 
Studies from South America refer to 8 studies in 
12 countries, published in the period 2003-2013 [26-33], 
while data from North America refer to 22 studies con-
ducted in the United States and published in the period 
2001-2014 [16, 17, 34, 53]. 
Data on Australia were obtained on the basis of 
7 studies published in the period 2000-2014 [54-60]. 
Presentation of data from the Eurasian continent 
takes into account the distribution of data from 13 
studies published in Asia in the period 2002-2013 from 
Japan, China, the Philippines, India, Iran, Oman, Malay-
sia, Taiwan, and Korea [61-73] and in Europe, publica-
tions of 9 studies in the period 2007-2013, from Spain, 
Turkey, the United Kingdom, France, Germany, and Italy 
[5, 36, 74, 80]. 
After reviewing the literature, the most common 
symptoms of menopause were selected and grouped 
as follows:
•	 sleep disorders – insomnia, waking and sleeping dif-
ficulties,
•	 sexual dysfunctions – reduced libido, urogenital dis-
orders,
•	 depressive disorders and irritability,
•	 hot flashes, excessive sweating,
•	 discomfort associated with muscle, joint pain – dis-
comfort of bone-joint system, osteoporosis.
Using the PubMed database we searched for rel-
evant articles, being guided by the search criteria – 
keywords for selected symptoms of menopause from 
different continents. The results were verified and un-
derwent descriptive statistics in order to compare the 
severity of symptoms in menopausal women living in 
different continents. 
Limitations
It was very difficulty to find a comparable number of 
available studies in each continent, often with a small 
population of women surveyed. Available studies were 
characterized by a variety of research protocols and use 
of different research tools, which created difficulty in 
defining and grouping of symptoms. The average age 
of occurrence of the first symptoms of menopause is 
different for women from different regions of the world; 
therefore in this paper the data concern women of 
a wide age range, between 40 and 64 years. The great-
est limitation for the elaboration of the data were the 
dates of scientific reports, often later than the date of 
the conducted study. Due to the availability of research 
of large populations of women, conducted long term, 
in this work only the year of publication of reports was 
used.
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Australia (on average in 82.3% of all women over the 
years 2002-2012), while the lowest level of these symp-
toms was observed in North America (on average in 
32% of examined women in the years 2006-2012). The 
average prevalence of sexual dysfunctions in women liv-
ing in Australia was 82.3%, and 69.8% in South Ameri-
ca, in Asia 63.5%, in Africa 60.3%, while in the group of 
women living in Europe it was 54.5% (Fig. 2). 
The analysis of the research shows that approxi-
mately 60% of women aged 40 to 64 years in the world 
report sexual dysfunctions.
In the literature estimating the prevalence of sexual 
disorders in women in different ages, the range of fre-
quency of disturbances is 25% to 63%, and the preva-
lence of dysfunction in postmenopausal women is even 
higher, reaching the level between 68% and 86.5% de-
pending on cultural, religious, ethnic, and individual dif-
ferences [83]. 
The largest study of women’s sexual activity re-
lated to psychological problems in women was carried 
out on a  representative sample of 50 003 American 
women between 18 and 101 years old in 2006. In this 
study, low desire (libido) was the most common prob-
lem reported by women at all ages, and women aged 
45-64 years mostly reported sexual dysfunctions in 
comparison with younger women and after 65 years 
of age [84]. 
More than 75% of women in middle age in the 
Study of Women’s Health Across the Nation (SWAN) 
reported that sex was moderately, and even important 
to them [85].  
The results of the Seattle Midlife Women’s Health 
Study show that women experience a decrease in de-
sire during late menopause and early post-menopause. 
Results and discussion
Sleep disorders 
The highest percentage (84% of all women) of sleep 
disorders was noted in 2012 in Africa and in Europe in 
2013 (73% of women). Sleep disorders were found in 
56% of women living in South America in 2012. The 
lowest prevalence of sleep disorders was reported in 
Australia in 2014, while in North America and Asia is 
the severity of these symptoms, over the years, rising 
to a level of 45-49% in the group of women. In Europe 
there was also an increase of sleep disorders (Fig. 1).
The review of available studies shows that about 
50% of women aged 40 to 64 years in the world report 
sleep disorders. Most often they concern insomnia and 
its characteristic forms [81].
Subjective feelings of sleep deterioration are report-
ed more often by perimenopausal and postmenopausal 
women, in contrast to pre-menopausal women [5, 10]; 
however, studies have reported that a sleep disorder in 
the premenopausal period affects around 16% to 42% 
of women and 35% to 60% in the postmenopausal pe-
riod [60]. Almost 40% of women surveyed during the 
Melbourne Midlife Women’s Health Project reported 
problems with sleeping in the late perimenopausal 
period and approximately 50% of women in the early 
postmenopausal period [82]. 
Sexual dysfunctions
The highest prevalence of sexual dysfunctions was 
observed in Africa in 2010 (92% of women) and in 
Australia in 2002 and 2011 (88% and 87% of women). 
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Fig. 1. Prevalence of sleep disorders
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Depressive disorders, irritability
Depressive disorders frequently require the distinc-
tion of depressive episodes in the course of schizo-af-
fective disorders, anxiety disorders, withdrawal and de-
mentia. The ICD-10 classification of depressive disorders 
includes psychiatric disorders belonging to the group of 
affective disorders. The term affective disorders is used 
in relation to the group of mental disorders in which the 
predominant symptoms are mood disorders. 
According to the analysis, the highest level of de-
pressive severity was noted in Europe in 2010 in Tur-
key (85% of all women), then in South America in 2003 
(82%) and in Africa in 2012 (81%). The lowest percent-
age of women reporting affective disorders was found 
in Australia (25% in 2009) and North America (28% in 
2008) – Figure 3. 
The average percentage of the severity of depres-
sive disorders in South America was 74%, in Europe 
61.3%, in Asia 49%, in North America 36%, and in Aus-
tralia 32.5%.
The analysis of the research shows that about 55% 
of women aged 40 to 64 years in the world report de-
pressive disorders.
Joffe et al. reported that women in perimenopausal 
age in 23% of cases experienced at least one episode of 
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Fig. 3. Prevalence of depressive disorders
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full-blown depression [3]. The risk of depressive disor-
ders increases in the premenopausal and perimeno-
pausal period and decreases in the postmenopausal 
period. The presence of previous episodes of depres-
sion before the period of menopause transition predis-
poses women to five times greater risk of depressive 
disorders in perimenopausal age. Australian studies 
have shown that women in the early postmenopausal 
period (up to 2-3 years after menopause) more often 
experience a  depressive disorder than those women 
who had menopause 4-10 years ago or more [86].
Hot flashes, night sweats
The highest incidence of hot flashes and sweating 
occurred in 2010 in Turkey, reaching 97% of the women 
surveyed. A high level of intensity of hot flashes was 
also reported in Australia in 2011 in 83% of cases. 
The highest average level of intensity of hot flashes 
and sweating occurred in Europe in 2007-2010 and 
amounted to 76.5% of women. Subsequently, 58.8% of 
women living in North America reported symptoms dis-
cussed in 2001-2014, 58% of women surveyed in Africa 
and Australia, 47% of women living in South America 
and 45% of women in Asia (Fig. 4).
The analysis of the research shows that about 57% 
of women aged 40 to 64 years in the world reported the 
occurrence of hot flashes and sweating.
Women experiencing the most intractable meno-
pausal symptoms such as hot flashes, fatigue, depres-
sive disorders, and sleep disorders also reported signifi-
cantly lower sexual desire [81]. 
In the research by Williams et al., in 4402 American 
women between 40 and 65 years old, 79% of women 
surveyed reported very distressing vasomotor symp-
toms in the form of 7 or more severe hot flashes per 
day [87]. Freeman and Sherif in 2007 found that the 
occurrence of vasomotor symptoms was influenced by 
climate, diet, lifestyle, functions that women held and 
their attitude to the aging process [88].
The research Study of Women’s Health Across the 
Nation Sleep Study indicates that a longer sleep latency 
time and its lower productivity were associated with 
the occurrence of anxiety symptoms in perimenopau-
sal women reporting vasomotor symptoms [53]. In the 
studies from Seattle it was found that the occurrence of 
hot flashes among other things, among perimenopau-
sal women is associated with sleep disorders, stress, 
depressive disorders, muscular and joint pain, and 
stress [81]. In the Penn Ovarian Aging study hot flashes 
were associated with sleep disorders, which can be ex-
plained by the domino hypothesis – that is, impaired 
well-being of women during the day because of awak-
enings and the additional occurrence of depressive dis-
orders (against this background) [89]. Theories based 
on the occurrence of sleep disturbances and vasomotor 
symptoms, however, are contradictory. 
Discomfort associated with muscle and joint pain
Similarly as in the case of hot flashes, the highest 
frequency of occurrence of discomfort associated with 
muscle and joint pain occurred in 2010 in Turkey, reach-
ing 95% of the surveyed women, while studies from 
France, Germany, Italy, Spain, and the United Kingdom 
provided information about the occurrence of these 
symptoms in only 18.30% of the women. Women living 
in South America most commonly reported symptoms 
of discomfort in muscles and joints in the years 2007-
2013, and the average percentage of these reports was 
78%. Slightly fewer women living in Africa (77%) and 
North America (76.25%) suffer from these ailments. In 
Asia ailments were reported on average by 58% of all 
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Fig. 4. Percentage of hot flashes, excessive sweating
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of all women surveyed. The lowest prevalence of these 
symptoms occurred in Australia, with 34.3% of women 
(Fig. 5).
The research results indicate that a symptom of dis-
comfort associated with muscle or joint pain was noted 
in 62% of women in the world from 40 to 64 years old.
Symptoms of discomfort in muscles and joints of-
ten worsen during menopause and are associated with 
involution changes. At the age of about 30 peak bone 
mass is reached, and then over time, there is a decrease 
in bone mineral density. This process after menopause 
is estimated at 1.2% to 2% loss per year [90]. More se-
vere bone loss begins approximately 2-3 years before 
the last monthly bleeding, with a decrease in the syn-
thesis of estrogen, which is considered one of the most 
important elements of the complex pathogenesis of os-
teoporosis. Hypoestrogenism accelerates the destruc-
tive action of osteoclasts and inhibits the activity of 
osteoblasts, which may lead to the development of os-
teoporosis [91]. On the ground of involutional changes 
and developing somatic diseases there occur degenera-
tive bone-joint system and neurological changes, which 
in turn contribute to the feeling by women during 
menopause of muscle pain with varying cause-effect 
background. 
Conclusions and summary
Women around the world suffer from ailments 
characteristic for the menopausal period regardless of 
ethnic origin, skin color, and socio-demographic fac-
tors. The obtained results indicate that the severity of 
symptoms on different continents, in the countries con-
cerned, which allows us to draw attention to custom-
ized treatment programs for women and assessing the 
need for professional medical assistance in relation to 
the needs. 
The number of studies carried out in Africa is still 
insufficient. The prevalence of menopausal symptoms 
in African women is disconcertingly high. The highest 
prevalence of sleep disorders, very high prevalence of 
depressive disorders, and high prevalence of sexual 
dysfunction were noted. Dangerously, the percentage of 
women reporting vasomotor symptoms increased from 
39% of women surveyed in 2009 to 77% of women in 
2012, and of women suffering from ailments of the 
bone-joint system from 59% in 2009 to 84% in 2012. 
On the basis of these results, we can state that the wor-
rying situation of women in Africa is caused by the low 
availability of specialist health care, lack of implemen-
tation of prevention programs and the difficult socio-
economic situation of the countries. There is an urgent 
need to focus attention and resources to take care of 
African women.
Women living in South America particularly com-
plain about depressive disorders, sexual dysfunction, 
menopause and discomfort in muscles and joints, but 
there is a  significant reduction in the percentage of 
women suffering from hot flashes, with 70% of the 
women reporting ailments in 2003 to 18% in 2013, 
which was satisfactory thanks to large-scale health 
promotion of the menopausal period and interests of 
women in ways to treat the symptoms of menopause. 
In the literature there are reports indicating that vaso-
motor menopausal symptoms were a  significant pre-
dictor of full-blown depression [92]. Many experts 
believe, however, that depressive disorders in women 
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Fig. 5. Prevalence of discomfort associated with myalgia and arthralgia
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chosocial factors, which in this stage of life can cause 
many problems. Some studies suggest that the increase 
in symptoms is more similar to other factors, such as 
the state of physical health, or psychosocial stressors, 
and not to menopause transition [93]. In respect of the 
impact of socio-economic factors the risk of depressive 
disorders is affected by: living in urban areas, lower 
monthly income, and lower education [94, 95].  
In North America, over the years 2003-2008, there 
was a slight increase in sleep disorders, the lowest in-
tensity level of sexual dysfunctions, and a low percent-
age of depressive disorders. Over the years 2001-2014 
there has been observed a reduction in the percentage 
of women reporting vasomotor symptoms, from 77% 
of women tested to 46% of women in 2014, which in-
dicates a greater attention to women’s health and the 
introduction of effective therapies. The symptoms most 
commonly reported by women in the United States are 
associated with muscle pains and joint aches.
In Australia, there was noted the lowest prevalence 
of sleep disorders and discomfort associated with 
muscle pains and joint aches, and the lowest average 
prevalence of depressive disorders. There were, howev-
er, a disturbingly high percentage of women reporting 
vasomotor symptoms (58%) and the highest average 
prevalence of sexual dysfunction in women living in 
Australia (82.3%). 
In the group of women living in Asia there was 
a slight increase in sleep disorders over the years 2002-
2013, rising to a level of 49%. There was an alarming 
increase in the percentage of women reporting depres-
sive disorders from 34% in 2002 to 66% of women in 
2013 and the intensity of vasomotor symptoms from 
38% to 58% of women surveyed. Despite this, the av-
erage prevalence of hot flashes and excessive sweat-
ing is still the lowest in Asia. Research has shown that 
women who reported vasomotor symptoms had an 
increased risk of a depressive episode. Bromberger et 
al. through the Study of Women’s Health Across the 
Nation (SWAN) confirmed that vasomotor menopausal 
symptoms were a significant predictor of full-blown de-
pression [93]. 
In Europe there was noted a  higher frequency of 
sleep disorders, high average percentage of the inten-
sity of depressive disorders (61.3%), and a significant 
increase in the occurrence of vasomotor symptoms in 
the years 2007-2010, while there was a  reduction in 
reported pain symptoms associated with muscles and 
joints in the years 2010-2013. In the period 2007-2013 
there was also a slight increase in reported sexual dys-
function.
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